Arrow’s LionHeart To Receive New Power Source; U.S. Trial Awaits EU Testing
This article was originally published in The Gray Sheet
Executive Summary
A European pilot study of Arrow International's CorAide continuous-flow ventricular assist system is expected to resume by year-end, following ongoing bench testing of modifications, the firm says
You may also be interested in...
Arrow Contemplates Fate Of LVAD Business; WorldHeart, Thoratec Start Trials
Arrow International's board of directors will assess the future commercial potential of its left-ventricular assist devices at a meeting April 6-7
Arrow Contemplates Fate Of LVAD Business; WorldHeart, Thoratec Start Trials
Arrow International's board of directors will assess the future commercial potential of its left-ventricular assist devices at a meeting April 6-7
Arrow Upgrades Manufacturing/Sales Operations, Reviews LVAD Program
Arrow International expects to spend $40 mil. over the next two years to streamline its global manufacturing operations, the company reported during a Jan. 19 annual shareholders meeting